CLASS II ONGOING Drug recall · Reported 14 May 2025 · FDA Enforcement Report
Carboxymethylcellulose Sodium Ophthalmic Solution recalled
BRS Analytical Services is recalling Carboxymethylcellulose Sodium Ophthalmic Solution 5%, Carboxymethlycellulose Sodium 5%, distributed nationwide in the US. The recall was initiated on 23 Apr 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0406-2025
- FDA event ID
- 96741
- Recalling firm
- BRS Analytical Services, Saint Louis, MO
- Manufacturer
- AvPAK
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 23 Apr 2025
- FDA classified
- 6 May 2025
- Reported
- 14 May 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Eye Drops
Timeline
| 23 Apr 2025 | Recall initiated by company | |
| 6 May 2025 | Classified by FDA | +13 days |
| 14 May 2025 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP deviations and lack of assurance of sterility.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Carboxymethlycellulose Sodium 0.5% Eye Lubricant, Lubricating Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-068-15.
Where it was distributed
Nationwide in the USA
Questions about this recall
Is Carboxymethylcellulose Sodium Ophthalmic Solution 5%, Carboxymethlycellulose Sodium 5% recalled?
Yes. BRS Analytical Services recalled Carboxymethylcellulose Sodium Ophthalmic Solution 5%, Carboxymethlycellulose Sodium 5% on 23 Apr 2025. The recall is Class II and its status is Ongoing. Recall number D-0406-2025.
Why was it recalled?
cGMP deviations and lack of assurance of sterility.
Which lots are affected?
Lot, expiry: Lot 103, exp 4/26/25; Lot 104, exp 5/03/25; Lot 108, exp 6/29/25; Lot 109, exp 7/18/25; Lot 110, exp 8/17/25; Lot 111, exp 8/22/25; Lot 112, exp 8/27/25; Lot 113, exp 9/18/25; Lot 125, exp 10/23/25; Lot 130, exp 11/09/25; Lot 131, exp 11/14/25; Lot 132, exp 11/27/25; Lot 133, exp 11/30/25; Lot 134, exp 12/05/25; Lot 135, exp 12/11/25; Lot 136, exp 12/14/25; Lot 137, exp 1/02/26; Lot 139, exp 1/15/26; Lot 140, exp 1/19/26; Lot 141, exp 1/25/26; Lot 151, exp 3/18/26; Lot 152, exp 3/21/26; Lot 153, exp 3/25/26; Lot 154, exp 3/28/26; Lot 155, exp 4/01/26; Lot 156, exp 4/08/26; Lot 157, exp 4/11/26; Lot 160, exp 4/26/26; Lot 180, exp 8/08/26; Lot 181, exp 8/12/26; Lot 182, exp 8/18/26; Lot 183, exp 8/21/26; Lot 184, exp 8/26/26; Lot 185, exp 9/04/26; Lot 186, exp 9/09/26; Lot 187, exp 9/16/26; Lot 188, exp 9/18/26; Lot 189, exp 9/21/26; Lot 190, exp 9/25/26; Lot 191, exp 9/28/26; Lot 192, exp 10/02/26; Lot 208, exp 12/11/26; Lot 209, exp 12/16/26; Lot 212, exp 1/15/27; Lot 213, exp 1/21/27; Lot 214, exp 1/24/27; Lot 215, exp 2/02/27; Lot 216, exp 2/04/27; Lot 224, exp 3/27/27.
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from BRS Analytical Services
All 5| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lubricant Eye Drops Solution recalled by BRS Analytical ServicesLubricant Eye Drops Solution | BRS Analytical Services | Sterility | Nationwide |
| Drug | CLASS II | Polyvinyl Alcohol Ophthalmic Solution recalledPolyvinyl Alcohol | BRS Analytical Services | Sterility | Nationwide |
| Drug | CLASS II | Carboxymethylcellulose Sodium Ophthalmic Gel recalled | BRS Analytical Services | Sterility | Nationwide |
| Drug | CLASS II | Artificial Tears Ophthalmic Solution recalled by BRS Analytical ServicesArtificial Tears | BRS Analytical Services | Sterility | Nationwide |
Other Carboxymethylcellulose recalls
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Carboxymethylcellulose Sodium Ophthalmic Solution recalled by AvKARECarboxymethylcellulose Sodium | AvKARE | Packaging Defects | Nationwide |
| Drug | CLASS I | Leader Dry Eye Relief (Carboxymethylcellulose Sodium 1%) recalledDry Eye Relief | Kilitch Healthcare India | Sterility | Nationwide |
| Drug | CLASS I | Leader Lubricant Eye Drops (Carboxymethylcellulose Sodium 5%) recalledLubricant Drops | Kilitch Healthcare India | Sterility | Nationwide |
| Drug | CLASS I | Leader Lubricant Eye Drops (Carboxymethylcellulose Sodium, 5%) recalledLubricant Drops | Cardinal Health | Sterility | Nationwide |
| Drug | CLASS I | Leader Dry Eye Relief (Carboxymethylcellulose Sodium, 1%) recalledDry Eye Relief | Cardinal Health | Sterility | Nationwide |